Literature DB >> 12801971

Severe polyneuropathy complicating active Crohn's disease: rapid response to Infliximab.

S Rodinò, N Saccà, T D'Amico, A Fragomeni, A Giglio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12801971      PMCID： PMC1773730          DOI： 10.1136/gut.52.7.1070

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Re: Triantafillidis et al.--Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment.

Authors:  D S Fefferman; M Alsahli; P J Lodhavia; S A Shah; R J Farrell
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

Review 2.  A critical assessment of new therapies in inflammatory bowel disease.

Authors:  Paul Rutgeerts
Journal:  J Gastroenterol Hepatol       Date:  2002-02       Impact factor: 4.029

Review 3.  Biologic therapy of inflammatory bowel disease.

Authors:  William J Sandborn; Stephan R Targan
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682
  3 in total
  1 in total

1.  Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Authors:  Maria G Tektonidou; John Serelis; Fotini N Skopouli
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.